Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer.
chemotherapy
gene expression
oesophageal cancer
pathological response
predictive biomarkers
radiotherapy
Journal
Gastroenterology report
ISSN: 2052-0034
Titre abrégé: Gastroenterol Rep (Oxf)
Pays: England
ID NLM: 101620508
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
20
12
2019
revised:
21
04
2020
accepted:
15
07
2020
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
15
1
2021
Statut:
epublish
Résumé
Oesophageal cancer is a devastating disease with poor outcomes and is the sixth leading cause of cancer death worldwide. In the setting of resectable disease, there is clear evidence that neoadjuvant chemotherapy and chemoradiotherapy result in improved survival. Disappointingly, only 15%-30% of patients obtain a histopathological response to neoadjuvant therapy, often at the expense of significant toxicity. There are no predictive biomarkers in routine clinical use in this setting and the ability to stratify patients for treatment could dramatically improve outcomes. In this review, we aim to outline current progress in evaluating predictive transcriptomic biomarkers for neoadjuvant therapy in oesophageal cancer and discuss the challenges facing biomarker development in this setting. We place these issues in the wider context of recommendations for biomarker development and reporting. The majority of studies focus on messenger RNA (mRNA) and microRNA (miRNA) biomarkers. These studies report a range of different genes involved in a wide variety of pathways and biological processes, and this is explained to a large extent by the different platforms and analysis methods used. Many studies are also vastly underpowered so are not suitable for identifying a candidate biomarker. Multiple molecular subtypes of oesophageal cancer have been proposed, although little is known about how these relate to clinical outcomes. We anticipate that the accumulating wealth of genomic and transcriptomic data and clinical trial collaborations in the coming years will provide unique opportunities to stratify patients in this poor-prognosis disease and recommend that future biomarker development incorporates well-designed retrospective and prospective analyses.
Identifiants
pubmed: 33442473
doi: 10.1093/gastro/goaa065
pii: goaa065
pmc: PMC7793050
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
411-424Informations de copyright
© The Author(s) 2020. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University.
Références
Nat Methods. 2005 May;2(5):337-44
pubmed: 15846360
Int Immunopharmacol. 2017 Oct;51:165-170
pubmed: 28843907
Cancer Cell Int. 2018 Jul 11;18:99
pubmed: 30008616
Sci Rep. 2018 May 8;8(1):7265
pubmed: 29739952
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Comput Med Imaging Graph. 2017 Sep;60:42-49
pubmed: 28087102
Clin Colorectal Cancer. 2011 Mar 1;10(1):48-56
pubmed: 21609936
BMC Cancer. 2016 Jul 19;16:503
pubmed: 27435280
BMC Bioinformatics. 2006 Jun 02;7:276
pubmed: 16749918
Transl Cancer Res. 2015 Jun;4(3):256-269
pubmed: 26213686
Nat Genet. 2013 May;45(5):478-86
pubmed: 23525077
Nature. 2011 Jan 13;469(7329):156-7
pubmed: 21228852
Cancer. 2003 Oct 1;98(7):1521-30
pubmed: 14508841
Clin Cancer Res. 2009 Sep 1;15(17):5473-7
pubmed: 19706812
Cancer Med. 2016 Oct;5(10):2879-2885
pubmed: 27577754
Eur J Cancer. 2013 Jun;49(9):2116-25
pubmed: 23481512
J Biol Chem. 2000 Jul 21;275(29):22313-23
pubmed: 10781587
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
N Engl J Med. 2008 Oct 23;359(17):1757-65
pubmed: 18946061
Am J Surg. 1993 May;165(5):558-60
pubmed: 8488936
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D258-61
pubmed: 14681407
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
J Clin Oncol. 2005 Jul 1;23(19):4330-7
pubmed: 15781882
Surg Oncol. 2017 Dec;26(4):460-472
pubmed: 29113666
J Clin Oncol. 2006 Jan 10;24(2):259-67
pubmed: 16344314
J Clin Oncol. 2015 Nov 20;33(33):3968-71
pubmed: 26392104
Nucleic Acids Res. 2003 Oct 1;31(19):5676-84
pubmed: 14500831
Nature. 2017 Jan 12;541(7636):169-175
pubmed: 28052061
J Gastroenterol. 2017 Jun;52(6):705-714
pubmed: 27671002
J Clin Oncol. 2005 Mar 20;23(9):2078-93
pubmed: 15774796
Nat Rev Genet. 2001 Jun;2(6):418-27
pubmed: 11389458
Urol Oncol. 2010 Nov-Dec;28(6):655-61
pubmed: 19375957
Int J Colorectal Dis. 2010 Apr;25(4):515-21
pubmed: 20012971
Cancer Cell Int. 2018 Mar 16;18:38
pubmed: 29568233
J Transl Med. 2014 Aug 29;12:233
pubmed: 25169763
Nucleic Acids Res. 2007;35(15):e99
pubmed: 17686789
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
Clin Cancer Res. 2010 Jan 1;16(1):330-7
pubmed: 20028767
Ann Surg Oncol. 2018 Sep;25(9):2731-2738
pubmed: 29987600
Lung Cancer. 2010 Feb;67(2):170-6
pubmed: 19446359
J Clin Oncol. 2008 Apr 1;26(10):1626-34
pubmed: 18316791
Clin Cancer Res. 2007 Feb 1;13(3):912-9
pubmed: 17289885
Am J Surg. 2017 May;213(5):915-920
pubmed: 28385379
Nat Genet. 2016 Oct;48(10):1131-41
pubmed: 27595477
J Cancer Res Clin Oncol. 2015 Mar;141(3):453-63
pubmed: 25273507
Ann Oncol. 2014 Sep;25(9):1769-1774
pubmed: 24907633
J Natl Cancer Inst. 2018 Aug 1;110(8):803-811
pubmed: 29873743
J Natl Cancer Inst. 2005 Jan 19;97(2):142-6
pubmed: 15657344
BMC Bioinformatics. 2002 Aug 23;3:22
pubmed: 12194703
Br J Surg. 2017 Dec;104(13):1816-1828
pubmed: 28944954
Ann Surg. 2009 Nov;250(5):729-37
pubmed: 19801928
Ann Surg Oncol. 2007 Dec;14(12):3602-9
pubmed: 17896157
J Clin Oncol. 2005 Dec 20;23(36):9067-72
pubmed: 16172462
Chin J Cancer. 2015 Sep 14;34(10):439-49
pubmed: 26369414
Gastroenterology. 2018 Jan;154(2):360-373
pubmed: 28823862
Nucleic Acids Res. 2015 Jan;43(Database issue):D36-42
pubmed: 25355515
Cancer. 2017 Nov 1;123(21):4106-4113
pubmed: 28885712
Cancer. 2014 Dec 1;120(23):3635-41
pubmed: 25091571
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
J Natl Cancer Inst. 2009 Nov 4;101(21):1446-52
pubmed: 19815849
Ann Oncol. 2015 Apr;26(4):624-644
pubmed: 25214541
J Exp Clin Cancer Res. 2018 Mar 12;37(1):56
pubmed: 29530057
J Clin Oncol. 2011 May 1;29(13):1715-21
pubmed: 21444866
Gut. 2019 Nov;68(11):1918-1927
pubmed: 30852560
Cancer. 2005 Apr 1;103(7):1347-55
pubmed: 15719440
Pharmacogenomics. 2010 Aug;11(8):1105-13
pubmed: 20712528
Ann Thorac Surg. 2012 Oct;94(4):1094-102; discussion 1102-3
pubmed: 22939244
EMBO Mol Med. 2012 Mar;4(3):143-59
pubmed: 22351564
Gut. 2015 Mar;64(3):381-7
pubmed: 25320104
Pharmacogenomics. 2010 Jan;11(1):55-64
pubmed: 20017672
Clin Cancer Res. 2012 Sep 15;18(18):5144-53
pubmed: 22847808
Jpn J Clin Oncol. 2013 Jul;43(7):752-5
pubmed: 23625063
PLoS One. 2015 Jul 29;10(7):e0134180
pubmed: 26221725
Nat Rev Genet. 2009 Jan;10(1):57-63
pubmed: 19015660
Oncotarget. 2016 Nov 15;7(46):75763-75773
pubmed: 27716621
BMC Cancer. 2017 Jun 3;17(1):401
pubmed: 28578652
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
PLoS One. 2017 Nov 14;12(11):e0188098
pubmed: 29136005
Ann Surg. 2016 May;263(5):942-8
pubmed: 26445467
Nat Genet. 2016 Dec;48(12):1500-1507
pubmed: 27749841
J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8
pubmed: 18840817
Nucleic Acids Res. 1999 Jan 1;27(1):29-34
pubmed: 9847135
Tumour Biol. 2016 Oct 10;:
pubmed: 27726103
Int J Cancer. 2013 Nov 15;133(10):2454-63
pubmed: 23649428
J Clin Oncol. 2008 Mar 1;26(7):1086-92
pubmed: 18309943
Mol Med. 2016 May 23;22:
pubmed: 27254108
Surg Today. 2014 Mar;44(3):421-8
pubmed: 23605218
Gut. 2013 Oct;62(10):1406-14
pubmed: 22917659
Ann Surg. 2016 Nov;264(5):839-846
pubmed: 27741011
Cell Rep. 2019 Dec 10;29(11):3367-3373.e4
pubmed: 31825821
Nucleic Acids Res. 2005 Oct 19;33(18):5914-23
pubmed: 16237126
Gastroenterology. 2018 Jan;154(2):390-405
pubmed: 28780073
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
N Engl J Med. 2006 Jul 6;355(1):11-20
pubmed: 16822992
Gut. 2009 Jan;58(1):127-43
pubmed: 19091831
Int J Oncol. 2010 Nov;37(5):1113-20
pubmed: 20878059
Exp Biol Med (Maywood). 2018 Feb;243(3):213-221
pubmed: 29405771
Nat Rev Genet. 2009 Oct;10(10):704-14
pubmed: 19763153
Lancet Oncol. 2015 Sep;16(9):1090-1098
pubmed: 26254683
Oncotarget. 2017 Dec 11;9(1):1028-1040
pubmed: 29416674
J Mol Med (Berl). 2012 Dec;90(12):1449-58
pubmed: 22706599
PLoS One. 2015 Sep 10;10(9):e0137036
pubmed: 26355298
PLoS Med. 2012;9(5):e1001216
pubmed: 22675273
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
pubmed: 18663219
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
J Thorac Oncol. 2019 Jul;14(7):1156-1171
pubmed: 30999111
Curr Biol. 2003 Nov 11;13(22):1985-90
pubmed: 14614825
Nat Genet. 2019 Mar;51(3):506-516
pubmed: 30718927
Annu Rev Pathol. 2014;9:287-314
pubmed: 24079833
Nat Rev Cancer. 2006 Nov;6(11):857-66
pubmed: 17060945
Clin Cancer Res. 2018 Jan 15;24(2):486-498
pubmed: 29101304
Lancet. 2002 May 18;359(9319):1727-33
pubmed: 12049861
Cancer. 1994 Jun 1;73(11):2680-6
pubmed: 8194005
Nat Biotechnol. 2006 Sep;24(9):1151-61
pubmed: 16964229
Lancet. 2019 May 11;393(10184):1948-1957
pubmed: 30982686
J Transl Med. 2018 Apr 25;16(1):109
pubmed: 29695253
N Engl J Med. 2012 May 31;366(22):2074-84
pubmed: 22646630
Eur Surg Res. 2016;56(3-4):141-53
pubmed: 26867151
Eur J Surg Oncol. 2004 Nov;30(9):963-71
pubmed: 15498642